Pipeline Review on Diabetic Gastroparesis Therapeutic Industry, H1 2014

About This Presentation
Title:

Pipeline Review on Diabetic Gastroparesis Therapeutic Industry, H1 2014

Description:

“Diabetic Gastroparesis - Pipeline Review, H1 2014” report provides a review of the products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. – PowerPoint PPT presentation

Number of Views:182

less

Transcript and Presenter's Notes

Title: Pipeline Review on Diabetic Gastroparesis Therapeutic Industry, H1 2014


1
Diabetic Gastroparesis - Pipeline Review, H1 2014
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
  • Published January 2014
  • Single User PDF US 2000
  • Corporate User PDF US 6000

2
Diabetic Gastroparesis - Pipeline Review,
H1 2014
  • Diabetic Gastroparesis - Pipeline Review, H1 2014
    provides an overview of the indications
    therapeutic pipeline. This report provides
    information on the therapeutic development for
    Diabetic Gastroparesis, complete with latest
    updates, and special features on late-stage and
    discontinued projects. It also reviews key
    players involved in the therapeutic development
    for Diabetic Gastroparesis. Diabetic
    Gastroparesis- Pipeline Review, Half Year is
    built using data and information sourced from
    proprietary databases, Company/University
    websites, SEC filings, investor presentations and
    featured press releases from company/university
    sites and industry-specific third party sources,
    put together by research team.
  • Scope
  • A snapshot of the global therapeutic scenario for
    Diabetic Gastroparesis.
  • A review of the Diabetic Gastroparesis products
    under development by companies and
    universities/research institutes based on
    information derived from company and
    industry-specific sources.
  • Coverage of products based on various stages of
    development ranging from discovery till
    registration stages.
  • A feature on pipeline projects on the basis of
    monotherapy and combined therapeutics.
  • Inquiry Before Buying on this Report _at_
    http//www.reportsnreports.com/contacts/InquiryBef
    oreBuy.aspx?name274907

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Diabetic Gastroparesis - Pipeline Review,
H1 2014
  • Coverage of the Diabetic Gastroparesis pipeline
    on the basis of route of administration and
    molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.
  • Reasons to buy
  • Identify and understand important and diverse
    types of therapeutics under development for
    Diabetic Gastroparesis.
  • Identify emerging players with potentially strong
    product portfolio and design effective
    counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by
    identifying players of the most promising
    pipeline.
  • Devise corrective measures for pipeline projects
    by understanding Diabetic Gastroparesis pipeline
    depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and scope.
  • Modify the therapeutic portfolio by identifying
    discontinued projects and understanding the
    factors that drove them from pipeline.
  • Inquire for Discount _at_ http//www.reportsnreports.
    com/contacts/Discount.aspx?name274907

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Diabetic Gastroparesis - Pipeline Review,
H1 2014
  • List of Tables
  • Number of Products under Development for Diabetic
    Gastroparesis, H1 2014 7
  • Number of Products under Development for Diabetic
    Gastroparesis - Comparative Analysis, H1 2014
  • Number of Products under Development by
    Companies, H1 2014 9
  • Comparative Analysis by Late Stage Development,
    H1 2014 10
  • Comparative Analysis by Clinical Stage
    Development, H1 2014 11
  • Comparative Analysis by Early Stage Development,
    H1 2014 12
  • Comparative Analysis by Unknown Stage
    Development, H1 2014 13
  • Products under Development by Companies, H1 2014
    14
  • Diabetic Gastroparesis - Pipeline by Theravance,
    Inc., H1 2014 15
  • Diabetic Gastroparesis - Pipeline by Evoke
    Pharma, Inc., H1 2014 16
  • Diabetic Gastroparesis - Pipeline by Targacept,
    Inc., H1 2014 17
  • Diabetic Gastroparesis - Pipeline by Cempra,
    Inc., H1 2014 18
  • Diabetic Gastroparesis - Pipeline by Rhythm
    Pharmaceuticals, H1 2014 19
  • Assessment by Monotherapy Products, H1 2014 20
  • Number of Products by Stage and Mechanism of
    Action, H1 2014 24

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Diabetic Gastroparesis - Pipeline Review,
H1 2014
  • Number of Products by Stage and Route of
    Administration, H1 2014 26
  • Number of Products by Stage and Molecule Type, H1
    2014 28
  • Number of Products by Stage and Therapeutic
    Class, H1 2014 31
  • Diabetic Gastroparesis Therapeutics - Recent
    Pipeline Updates, H1 2014 38
  • Diabetic Gastroparesis - Dormant Projects, H1
    2014 42
  • Diabetic Gastroparesis - Discontinued Products,
    H1 2014 43
  • List of Figures
  • Number of Products under Development for Diabetic
    Gastroparesis, H1 2014 7
  • Number of Products under Development for Diabetic
    Gastroparesis - Comparative Analysis, H1 2014 8
  • Number of Products under Development by
    Companies, H1 2014 9
  • Assessment by Monotherapy Products, H1 2014 20
  • Number of Products by Top 10 Target, H1 2014 21
  • Number of Products by Stage and Top 10 Target, H1
    2014 22
  • Number of Products by Top 10 Mechanism of Action,
    H1 2014 23

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
Diabetic Gastroparesis - Pipeline Review,
H1 2014
  • Number of Products by Stage and Top 10 Mechanism
    of Action, H1 2014 24
  • Number of Products by Top 10 Route of
    Administration, H1 2014 25
  • Number of Products by Stage and Top 10 Route of
    Administration, H1 2014 26
  • Number of Products by Top 10 Molecule Type, H1
    2014 27
  • Number of Products by Stage and Top 10 Molecule
    Type, H1 2014 28
  • Number of Products by Top 10 Therapeutic Class,
    H1 2014 29
  • Number of Products by Stage and Top 10
    Therapeutic Class, H1 2014 30
  • Complete report of 51 Pages is available _at_
    http//www.reportsnreports.com/reports/274907-diab
    etic-gastroparesis-pipeline-review-h1-2014.html .

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
Write a Comment
User Comments (0)